Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budenofalk vs Salofalk in active ulcerative colitis
NCT00747110Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Oct 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in ulcerative colitis (UC), sponsored by Dr. Falk Pharma GmbH. Started Oct 2007; status: completed.
02
Drugs
budesonide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00747110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747110.